A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid

被引：0
作者：
Carlo C. Quattrocchi
Daniele Santini
Paola Dell’Aia
Sara Piciucchi
Emanuele Leoncini
Bruno Vincenzi
Rosario Francesco Grasso
Giuseppe Tonini
Bruno Beomonte Zobel
机构：
[1] Centro Interdisciplinare per la Ricerca Bio-Medica,Department of Radiology
[2] University Campus Bio-Medico di Roma,Department of Oncology
[3] Statistica Sanitaria,undefined
[4] University La Sapienza,undefined
来源：
Skeletal Radiology | 2007年 / 36卷
关键词：
Bone metastases; Computed tomography; Zoledronic acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1121 / 1127
页数：6
相关论文
共 50 条
  • [41] Bone Turnover Markers as Predictors of Mortality Risk in Prostate Cancer Patients with Bone Metastases Following Treatment with Zoledronic Acid
    Jung, Klaus
    Miller, Kurt
    Wirth, Manfred
    Albrecht, Michael
    Lein, Michael
    EUROPEAN UROLOGY, 2011, 59 (04) : 604 - 612
  • [42] Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases
    Leto, G
    Badalamenti, G
    Arcara, C
    Crescimanno, M
    Flandina, C
    Tumminello, FM
    Incorvaia, L
    Gebbia, N
    Fulfaro, F
    ANTICANCER RESEARCH, 2006, 26 (1A) : 23 - 26
  • [43] Effect of zoledronic acid on serum angiogenic factors in patients with bone metastases
    Tas, Faruk
    Duranyildiz, Derya
    Oguz, Hilal
    Camlica, Hakan
    Yasasever, Vildan
    Topuz, Erkan
    MEDICAL ONCOLOGY, 2008, 25 (03) : 346 - 349
  • [44] Effect of zoledronic acid on bone mineral density in patients of celiac disease: A prospective, randomized, pilot study
    Kumar, Mukul
    Rastogi, Ashu
    Bhadada, Sanjay Kumar
    Bhansali, Anil
    Vaiphei, Kim
    Kochhar, Rakesh
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2013, 138 : 882 - 887
  • [45] Changes in serum bone turnover markers and bone mineral density Z-score in children with osteogenesis imperfecta after zoledronic acid treatment
    Jin, Jiahui
    Yue, Luo
    Lu, Yili
    Zhen, Zhichao
    Wu, Huiping
    Shan, Xiaoou
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (07) : 715 - 722
  • [46] Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours
    Santini, D
    Vincenzi, B
    Hannon, RA
    Brown, JE
    Dicuonzo, G
    Angeletti, S
    La Cesa, A
    Coleman, RE
    Tonini, G
    Budillon, A
    Caraglia, M
    Holen, I
    ONCOLOGY REPORTS, 2006, 15 (05) : 1351 - 1357
  • [47] The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer
    Hadji, Peyman
    Ziller, May
    Maurer, Tobias
    Autenrieth, Michael
    Muth, Mathias
    Ruebel, Amelie
    May, Christoph
    Birkholz, Katrin
    Diebel, Erhardt
    Gleissner, Jochen
    Rothe, Peter
    Gschwend, Juergen E.
    JOURNAL OF BONE ONCOLOGY, 2012, 1 (03) : 88 - 94
  • [48] Effects of zoledronic acid and ibandronate in the treatment of cancer pain in rats with lung cancer combined with bone metastases
    Wang, Gengshen
    Chen, Jiuyi
    Ma, Ruofei
    Xu, Weiyuan
    Yan, Chunlu
    Niu, Cunliang
    ONCOLOGY LETTERS, 2018, 16 (02) : 1696 - 1700
  • [49] Effect of zoledronic acid on serum angiogenic factors in patients with bone metastases
    Faruk Tas
    Derya Duranyildiz
    Hilal Oguz
    Hakan Camlica
    Vildan Yasasever
    Erkan Topuz
    Medical Oncology, 2008, 25 : 346 - 349
  • [50] Combined chemotherapy of zoledronic acid and pamidronate in the treatment of bone metastases from nonsmall cell lung cancer and the effects on pain stress and bone metabolic indices
    Huang, Kun
    Tang, Xiao
    Tang, Fang
    DRUG DEVELOPMENT RESEARCH, 2024, 85 (01)
12345